MedPath

SUBSTIPHARM

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:1
Completed:1

Trial Phases

1 Phases

Phase 1:3

Drug Approvals

18

CIMA_AEMPS:15
EMA:3

Drug Approvals

Efient

Authorization Status
Authorised
Approval Date
Feb 24, 2009
EMA

Efient

Authorization Status
Authorised
Approval Date
Feb 24, 2009
EMA

Evista

Authorization Status
Authorised
Approval Date
Aug 5, 1998
EMA

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.